CARsgen Therapeutics Holdings Balance Sheet Health
Financial Health criteria checks 5/6
CARsgen Therapeutics Holdings has a total shareholder equity of CN¥1.5B and total debt of CN¥129.1M, which brings its debt-to-equity ratio to 8.6%. Its total assets and total liabilities are CN¥2.1B and CN¥605.2M respectively.
Key information
8.6%
Debt to equity ratio
CN¥129.12m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.65b |
| Equity | CN¥1.50b |
| Total liabilities | CN¥605.18m |
| Total assets | CN¥2.10b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2171's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥183.7M).
Long Term Liabilities: 2171's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥421.5M).
Debt to Equity History and Analysis
Debt Level: 2171 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 2171's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2171 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 2171 has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 9.1% each year.